{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T17:45:42Z","timestamp":1769535942637,"version":"3.49.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03094-5","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T03:53:18Z","timestamp":1764561198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Calendula officinalis as a source of KRAS-targeted anticancer agents: a comprehensive computational assessment"],"prefix":"10.1007","volume":"43","author":[{"given":"Osama S.","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hezha O.","family":"Rasul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dler M. S.","family":"Shwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"3094_CR1","doi-asserted-by":"crossref","unstructured":"Christiani DC. Ambient air pollution and lung cancer: nature and nurture. Am J Respir Crit Care Med. 2021;204:752\u20133 (cited 26 Feb 2025). https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8528534\/.","DOI":"10.1164\/rccm.202107-1576ED"},{"key":"3094_CR2","doi-asserted-by":"crossref","unstructured":"Kanwal M, Ding XJ, Cao Y. Familial risk for lung cancer. Oncol Lett. 2017;13:535\u201342 (cited 26 Feb 2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/28356926\/.","DOI":"10.3892\/ol.2016.5518"},{"key":"3094_CR3","doi-asserted-by":"crossref","unstructured":"Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999;49:33\u201364 (cited 26 Feb 2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/10200776\/.","DOI":"10.3322\/canjclin.49.1.33"},{"key":"3094_CR4","doi-asserted-by":"crossref","unstructured":"Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P. Risk factors for lung cancer worldwide. Eur Respir J. 2016;48:889\u2013902 (cited 26 Feb 2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/27174888\/.","DOI":"10.1183\/13993003.00359-2016"},{"key":"3094_CR5","doi-asserted-by":"crossref","unstructured":"Goodman GE. Lung cancer. 1: Prevention of lung cancer. Thorax. 2002;57:994\u20139 (cited 26 Feb 2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/12403886\/.","DOI":"10.1136\/thorax.57.11.994"},{"key":"3094_CR6","doi-asserted-by":"crossref","unstructured":"Agonsanou H, Figueiredo R, Bergeron M. Risk factors for the development of lung cancer around the world: a review. Open Explor. 2023;4:1168\u201388 (cited 26 Feb 2025). https:\/\/www.explorationpub.com\/Journals\/em\/Article\/1001201.","DOI":"10.37349\/emed.2023.00201"},{"key":"3094_CR7","doi-asserted-by":"crossref","unstructured":"Luo J. KRAS mutation in pancreatic cancer. Semin Oncol. 2021;48:10 (cited 26 Feb 2025). https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8380752\/.","DOI":"10.1053\/j.seminoncol.2021.02.003"},{"key":"3094_CR8","doi-asserted-by":"crossref","unstructured":"Huang L, Guo Z, Wang F, Fu L. KRAS mutation: from undruggable to druggable in cancer. Signal Transduct Target Ther. 2021;6:1\u201320 (cited 26 Feb 2025). https:\/\/www.nature.com\/articles\/s41392-021-00780-4.","DOI":"10.1038\/s41392-021-00780-4"},{"key":"3094_CR9","doi-asserted-by":"crossref","unstructured":"Karimi N, Moghaddam SJ. KRAS-mutant lung cancer: targeting molecular and immunologic pathways, therapeutic advantages and restrictions. Cells. 2023;12:749 (cited 26 Feb 2025). https:\/\/www.mdpi.com\/2073-4409\/12\/5\/749\/htm.","DOI":"10.3390\/cells12050749"},{"key":"3094_CR10","doi-asserted-by":"crossref","unstructured":"Chen Y, Liu QP, Xie H, Ding J. From bench to bedside: current development and emerging trend of KRAS-targeted therapy. Acta Pharmacol Sin. 2024;45:686\u2013703 (cited 26 Sep 2025). https:\/\/www.nature.com\/articles\/s41401-023-01194-4.","DOI":"10.1038\/s41401-023-01194-4"},{"key":"3094_CR11","unstructured":"de Castro Carpe\u00f1o J, Belda-Iniesta C. KRAS mutant NSCLC, a new opportunity for the synthetic lethality therapeutic approach. Transl Lung Cancer Res. 2013;2:142 (cited 26 Feb 2025). https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4369862\/."},{"key":"3094_CR12","doi-asserted-by":"crossref","unstructured":"Hajd\u00fach M, Jan\u010d\u00edk S, Dr\u00e1bek J, Radzioch D. Clinical relevance of KRAS in human cancers. J Biomed Biotechnol. 2010 (cited 26 Feb 2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/20617134\/.","DOI":"10.1155\/2010\/150960"},{"key":"3094_CR13","doi-asserted-by":"crossref","unstructured":"Chinthareddy A, Oroszi T, Chinthareddy A, Oroszi T. Exploration of Kras mutations and their potential for being a target molecule in cancer chemotherapy. J Cancer Ther. 2023;14:257\u201376 (cited 26 Feb 2025). https:\/\/www.scirp.org\/journal\/paperinformation?paperid=125640.","DOI":"10.4236\/jct.2023.146022"},{"key":"3094_CR14","doi-asserted-by":"crossref","unstructured":"Bahar ME, Kim HJ, Kim DR. Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target Ther. 2023;8 (cited 26 Feb 2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/38105263\/.","DOI":"10.1038\/s41392-023-01705-z"},{"key":"3094_CR15","doi-asserted-by":"crossref","unstructured":"Ferreira A, Pereira F, Reis C, Oliveira MJ, Sousa MJ, Preto A. Crucial role of oncogenic KRAS mutations in apoptosis and autophagy regulation: therapeutic implications. Cells. 2022;11 (cited 26 Feb 2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/35883626\/.","DOI":"10.3390\/cells11142183"},{"key":"3094_CR16","doi-asserted-by":"crossref","unstructured":"Tomasini P, Walia P, Labbe C, Jao K, Leighl NB. Targeting the KRAS pathway in non-small cell lung cancer. Oncologist. 2016;21:1450\u201360 (cited 26 Feb 2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/27807303\/.","DOI":"10.1634\/theoncologist.2015-0084"},{"key":"3094_CR17","doi-asserted-by":"crossref","unstructured":"Mondal K, Posa MK, Shenoy RP, Roychoudhury S. KRAS mutation subtypes and their association with other driver mutations in oncogenic pathways. Cells. 2024;13:1221 (cited 26 Feb 2025). https:\/\/www.mdpi.com\/2073-4409\/13\/14\/1221\/htm.","DOI":"10.3390\/cells13141221"},{"key":"3094_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00432-012-1319-7","volume":"139","author":"I Messner","year":"2013","unstructured":"Messner I, Cadeddu G, Huckenbeck W, Knowles HJ, Gabbert HE, Baldus SE, et al. KRAS p. G13D mutations are associated with sensitivity to anti-EGFR antibody treatment in colorectal cancer cell lines. J Cancer Res Clin Oncol. 2013;139:201\u20139.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3094_CR19","doi-asserted-by":"crossref","unstructured":"Huynh M V., Hobbs GA, Schaefer A, Pierobon M, Carey LM, Diehl JN, et al. Functional and biological heterogeneity of KRASQ61 mutations. Sci Signal. 2022;15 (cited 26 Feb 2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/35944066\/.","DOI":"10.1126\/scisignal.abn2694"},{"key":"3094_CR20","doi-asserted-by":"publisher","unstructured":"Sos ML, Fischer S, Ullrich R, Peifer M, Heuckmann JM, Koker M, et al. Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer. Proc Natl Acad Sci USA. 2009;106:18351\u20136 (cited 26 Feb 2025). https:\/\/doi.org\/10.1073\/pnas.0907325106.","DOI":"10.1073\/pnas.0907325106"},{"key":"3094_CR21","doi-asserted-by":"publisher","unstructured":"Zhu C, Guan X, Zhang X, Luan X, Song Z, Cheng X, et al. Targeting KRAS mutant cancers: from druggable therapy to drug resistance. Mol Cancer. 2022;21:1\u201319 (cited 26 Feb 2025). https:\/\/doi.org\/10.1186\/s12943-022-01629-2.","DOI":"10.1186\/s12943-022-01629-2"},{"key":"3094_CR22","unstructured":"MD Anderson Cancer Center. Targeting the KRAS mutation for more effective cancer treatment. MD Anderson Cancer Center (cited 26 Feb 2025). https:\/\/www.mdanderson.org\/cancerwise\/targeting-the-kras-mutation-for-more-effective-cancer-treatment.h00-159458478.html."},{"key":"3094_CR23","doi-asserted-by":"crossref","unstructured":"Attieh F, Kourie HR. Breaking barriers: the latest insights into KRAS G12C inhibitors. Future Oncol. 2024;20:2685 (cited 26 Sep 2025). https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11572073\/.","DOI":"10.1080\/14796694.2024.2394009"},{"key":"3094_CR24","doi-asserted-by":"publisher","unstructured":"Mok TSK, Yao W, Duruisseaux M, Doucet L, Azk\u00e1rate Mart\u00ednez A, Gregorc V, et al. KRYSTAL-12: phase 3 study of adagrasib versus docetaxel in patients with previously treated advanced\/metastatic non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation. J Clin Oncol. 2024;42:LBA8509 (cited 26 Sep 2025). https:\/\/doi.org\/10.1200\/JCO.2024.42.17_suppl.LBA8509.","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA8509"},{"key":"3094_CR25","doi-asserted-by":"publisher","unstructured":"Wasiak K, Ciunowicz D, Kierasi\u0144ska-Ka\u0142ka A, W\u0119gierska M, Pacholczyk M, Rieske P, et al. The complex journey of targeting RAS in oncology. BMC Cancer. 2025;25:1\u201329 (cited 26 Sep 2025). https:\/\/doi.org\/10.1186\/s12885-025-14033-y.","DOI":"10.1186\/s12885-025-14033-y"},{"key":"3094_CR26","doi-asserted-by":"publisher","unstructured":"Prinsa, Saha S, Bulbul MZH, Ozeki Y, Alamri MA, Kawsar SMA. Flavonoids as potential KRAS inhibitors: DFT, molecular docking, molecular dynamics simulation and ADMET analyses. J Asian Nat Prod Res. 2024;26:955\u201392 (cited 26 Sep 2025). https:\/\/doi.org\/10.1080\/10286020.2024.2343821.","DOI":"10.1080\/10286020.2024.2343821"},{"key":"3094_CR27","doi-asserted-by":"crossref","unstructured":"Ahmad S, Kumar N, Gautam HK, Raza K. Probing the multitargeted potency of Theodrenaline and its comparative evaluation with Crizotinib against transferase, hydrolase, signalling, and apoptosis-related proteins to overcome lung cancer drug resistance. Int J Biol Macromol. 2025;308:142343 (cited 26 Sep 2025). https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0141813025028958?via%3Dihub.","DOI":"10.1016\/j.ijbiomac.2025.142343"},{"key":"3094_CR28","doi-asserted-by":"publisher","unstructured":"Yang L-Y, Lei S-Z, Xu W-J, Lai Y-X, Zhang Y-Y, Wang Y, et al. Rising above: exploring the therapeutic potential of natural product-based compounds in human cancer treatment. Tradit Med Res. 2025;10 (cited 26 Sep 2025). https:\/\/doi.org\/10.53388\/TMR20240618001.","DOI":"10.53388\/TMR20240618001"},{"key":"3094_CR29","doi-asserted-by":"crossref","unstructured":"Hakeem IJ, Alsharif FH, Aljadani M, Alabbas IF, Faqihi MS, Aloufi AH, et al. Molecular docking analysis of KRAS inhibitors for cancer management. Bioinformation. 2023;19:411 (cited 26 Sep 2025). https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10563554\/.","DOI":"10.6026\/97320630019411"},{"key":"3094_CR30","doi-asserted-by":"crossref","unstructured":"Zhang X, Wang R, Finiuk N, Stoika R, Lin H, Wang X, et al. Active compounds from Calendula officinalis flowers act via PI3K and ERK signaling pathways to offer neuroprotective effects against Parkinson\u2019s disease. Food Sci Nutr. 2023;12:450 (cited 26 Sep 2025). https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10804118\/.","DOI":"10.1002\/fsn3.3792"},{"key":"3094_CR31","doi-asserted-by":"crossref","unstructured":"Liu Y, Chen J, Li X, Fan Y, Peng C, Ye X, et al. Natural products targeting RAS by multiple mechanisms and its therapeutic potential in cancer: an update since 2020. Pharmacol Res. 2025;212 (cited 26 Sep 2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/39756556\/.","DOI":"10.1016\/j.phrs.2025.107577"},{"key":"3094_CR32","doi-asserted-by":"publisher","unstructured":"Wu Z, Xiang H, Wang X, Zhang R, Guo Y, Qu L, et al. Integrating network pharmacology, molecular docking and experimental verification to explore the therapeutic effect and potential mechanism of nomilin against triple-negative breast cancer. Mol Med. 2024;30:1\u201321 (cited 26 Sep 2025). https:\/\/doi.org\/10.1186\/s10020-024-00928-2.","DOI":"10.1186\/s10020-024-00928-2"},{"key":"3094_CR33","doi-asserted-by":"publisher","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The Protein Data Bank. Nucleic Acids Res. 2000;28:235\u201342 (cited 17 Jan 2025). https:\/\/doi.org\/10.1093\/nar\/28.1.235.","DOI":"10.1093\/nar\/28.1.235"},{"key":"3094_CR34","doi-asserted-by":"publisher","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455\u201361 (cited 17 Jan 2025). https:\/\/doi.org\/10.1002\/jcc.21334.","DOI":"10.1002\/jcc.21334"},{"key":"3094_CR35","doi-asserted-by":"crossref","unstructured":"Akkapeddi P, Hattori T, Khan I, Glasser E, Koide A, Ketavarapu G, Whaby M, Zuberi M, Teng KW, Lefler J, Maso L. Exploring switch II pocket conformation of KRAS (G12D) with mutant-selective monobody inhibitors. Proceedings of the National Academy of Sciences 2023 Jul 11;120(28):e2302485120.","DOI":"10.1073\/pnas.2302485120"},{"key":"3094_CR36","doi-asserted-by":"crossref","unstructured":"Hobbs GA, Baker NM, Miermont AM, Thurman RD, Pierobon M, Tran TH, Anderson AO, Waters AM, Diehl JN, Papke B, Hodge RG. Atypical KRASG12R mutant is impaired in PI3K signaling and macropinocytosis in pancreatic cancer. Cancer Discovery 2020 Jan 1;10(1):104\u201323.","DOI":"10.1158\/2159-8290.CD-19-1006"},{"key":"3094_CR37","doi-asserted-by":"crossref","unstructured":"Hunter JC, Manandhar A, Carrasco MA, Gurbani D, Gondi S, Westover KD. Biochemical and structural analysis of common cancer-associated KRAS mutations. Molecular Cancer Research 2015 Sep 1;13(9):1325\u201335.","DOI":"10.1158\/1541-7786.MCR-15-0203"},{"key":"3094_CR38","doi-asserted-by":"crossref","unstructured":"Popow J, Farnaby W, Gollner A, Kofink C, Fischer G, Wurm M, Zollman D, Wijaya A, Mischerikow N, Hasenoehrl C, Prokofeva P. Targeting cancer with small-molecule pan-KRAS degraders. Science 2024 Sep 20;385(6715):1338\u201347.","DOI":"10.1126\/science.adm8684"},{"key":"3094_CR39","doi-asserted-by":"crossref","unstructured":"Zhou ZW, Ambrogio C, Bera AK, Li Q, Li XX, Li L, Son J, Gondi S, Li J, Campbell E, Jin H. KRASQ61H preferentially signals through MAPK in a RAF dimer-dependent manner in non\u2013small cell lung cancer. Cancer Research 2020 Sep 1;80(17):3719\u201331.","DOI":"10.1158\/0008-5472.CAN-20-0448"},{"key":"3094_CR40","doi-asserted-by":"publisher","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, et al. PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res. 2021;49:D1388\u201395 (cited 17 Jan 2025). https:\/\/doi.org\/10.1093\/nar\/gkaa971.","DOI":"10.1093\/nar\/gkaa971"},{"key":"3094_CR41","doi-asserted-by":"publisher","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46:D1074\u201382 (cited 17 Jan 2025). https:\/\/doi.org\/10.1093\/nar\/gkx1037.","DOI":"10.1093\/nar\/gkx1037"},{"key":"3094_CR42","doi-asserted-by":"publisher","unstructured":"Rasul HO, Aziz BK, Ghafour DD, Kivrak A. In silico molecular docking and dynamic simulation of eugenol compounds against breast cancer. J Mol Model. 2022;28:1\u201318 (cited 17 Jan 2025). https:\/\/doi.org\/10.1007\/s00894-021-05010-w.","DOI":"10.1007\/s00894-021-05010-w"},{"key":"3094_CR43","first-page":"873","volume":"46","author":"HO Rasul","year":"2023","unstructured":"Rasul HO, Aziz BK, Mor\u00e1n GS, Mendoza-Huizar LH, Belhassan A, Candia LG, et al. A computational study of the antioxidant power of eugenol compared to vitamin C. Quim Nova. 2023;46:873\u201380.","journal-title":"Quim Nova"},{"key":"3094_CR44","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s00894-023-05592-7","volume":"29","author":"HO Rasul","year":"2023","unstructured":"Rasul HO, Sabir DK, Aziz BK, Guillermo Salgado M, Mendoza-Huizar LH, Belhassan A, et al. Identification of natural diterpenes isolated from Azorella species targeting dispersin B using in silico approaches. J Mol Model. 2023;29:182.","journal-title":"J Mol Model"},{"key":"3094_CR45","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.4067\/s0717-97072024000106025","volume":"69","author":"HO Rasul","year":"2024","unstructured":"Rasul HO, Sidiq KR, Hassan DA, Salgado MG, Mendoza-Huizar LH, Belhassan A, et al. Unveiling molecular interactions: coumarin derivatives and dengue virus protein targets. J Chil Chem Soc. 2024;69:6025\u201337.","journal-title":"J Chil Chem Soc"},{"key":"3094_CR46","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s11030-022-10475-9","volume":"27","author":"HO Rasul","year":"2023","unstructured":"Rasul HO, Aziz BK, Ghafour DD, Kivrak A. Discovery of potential mTOR inhibitors from Cichorium intybus to find new candidate drugs targeting the pathological protein related to the breast cancer: an integrated computational approach. Mol Divers. 2023;27:1141\u201362.","journal-title":"Mol Divers"},{"issue":"5","key":"3094_CR47","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1007\/s11030-022-10556-9","volume":"27","author":"HO Rasul","year":"2022","unstructured":"Rasul HO, Aziz BK, Ghafour DD, Kivrak A. Screening the possible anti-cancer constituents of Hibiscus rosa-sinensis flower to address mammalian target of rapamycin: an in silico molecular docking, HYDE scoring, dynamic studies, and pharmacokinetic prediction. Mol Divers. 2022;27(5):2273\u201396.","journal-title":"Mol Divers"},{"key":"3094_CR48","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.1080\/07391102.2023.2220040","volume":"42","author":"HO Rasul","year":"2023","unstructured":"Rasul HO, Thomas NV, Ghafour DD, Aziz BK, Salgado MG, Mendoza-Huizar LH, et al. Searching possible SARS-CoV-2 main protease inhibitors in constituents from herbal medicines using in silico studies. J Biomol Struct Dyn. 2023;42:4234\u201348.","journal-title":"J Biomol Struct Dyn"},{"key":"3094_CR49","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46:3\u201326 (cited 17 Jan 2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/11259830\/."},{"key":"3094_CR50","doi-asserted-by":"crossref","unstructured":"Kapetanovic IM. Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach. Chem Biol Interact. 2008;171:165\u201376 (cited 17 Jan 2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/17229415\/.","DOI":"10.1016\/j.cbi.2006.12.006"},{"key":"3094_CR51","doi-asserted-by":"publisher","unstructured":"Dong J, Wang NN, Yao ZJ, Zhang L, Cheng Y, Ouyang D, et al. ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. J Cheminform. 2018;10:1\u201311 (cited 17 Jan 2025). https:\/\/doi.org\/10.1186\/s13321-018-0283-x.","DOI":"10.1186\/s13321-018-0283-x"},{"key":"3094_CR52","doi-asserted-by":"publisher","unstructured":"Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C, et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 2021;49:W5\u201314 (cited 17 Jan 2025). https:\/\/doi.org\/10.1093\/nar\/gkab255.","DOI":"10.1093\/nar\/gkab255"},{"key":"3094_CR53","doi-asserted-by":"crossref","unstructured":"Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:1\u201313 (cited 17 Jan 2025). https:\/\/www.nature.com\/articles\/srep42717.","DOI":"10.1038\/srep42717"},{"key":"3094_CR54","doi-asserted-by":"publisher","unstructured":"Zhu H, Martin TM, Ye L, Sedykh A, Young DM, Tropsha A. Quantitative structure\u2013activity relationship modeling of rat acute toxicity by oral exposure. Chem Res Toxicol. 2009;22:1913\u201321 (cited 17 Jan 2025). https:\/\/doi.org\/10.1021\/tx900189p.","DOI":"10.1021\/tx900189p"},{"key":"3094_CR55","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Rodr\u00edguez M, Rosales-Hern\u00e1ndez CM, Mendieta-Wejebe EJ, Mart\u00ednez-Archundia M, Correa Basurto J. Current tools and methods in molecular dynamics (MD) simulations for drug design. Curr Med Chem. 2016;23:3909\u201324 (cited 17 Jan 2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/27237821\/.","DOI":"10.2174\/0929867323666160530144742"},{"key":"3094_CR56","doi-asserted-by":"crossref","unstructured":"Bowers KJ, Chow E, Xu H, Dror RO, Eastwood MP, Gregersen BA, et al. Scalable algorithms for molecular dynamics simulations on commodity clusters. In: Proceedings of 2006 ACM\/IEEE conference on supercomputing, SC\u201906, 2006 (cited 17 Jan 2025). https:\/\/www.researchgate.net\/publication\/220782318_Molecular_dynamics---Scalable_algorithms_for_molecular_dynamics_simulations_on_commodity_clusters.","DOI":"10.1145\/1188455.1188544"},{"issue":"5","key":"3094_CR57","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1063\/1.467468","volume":"101","author":"GJ Martyna","year":"1994","unstructured":"Martyna GJ, Tobias DJ, Klein ML. Constant pressure molecular dynamics algorithms. J Chem Phys. 1994;101(5):4177\u201389 (cited 17 Jan 2025).","journal-title":"J Chem Phys"},{"key":"3094_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.indcrop.2024.118571","volume":"214","author":"V Tavallali","year":"2024","unstructured":"Tavallali V, Rahmati S, Bahmanzadegan A, Lasibi MJM. Phenolic profile and evaluation of antimicrobial and anticancer activities of Calendula officinalis L. using exogenous polyamines application. Ind Crop Prod. 2024;214:118571.","journal-title":"Ind Crop Prod"},{"key":"3094_CR59","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jpba.2004.12.034","volume":"38","author":"G Matysik","year":"2005","unstructured":"Matysik G, W\u00f3jciak-Kosior M, Paduch R. The influence of Calendula officinalis flos extracts on cell cultures, and the chromatographic analysis of extracts. J Pharm Biomed Anal. 2005;38:285\u201392.","journal-title":"J Pharm Biomed Anal"},{"key":"3094_CR60","unstructured":"Masih M, Khan U. Diverse belongings of Calendula officinalis (cited 19 July 2024). https:\/\/www.researchgate.net\/publication\/273144539."},{"key":"3094_CR61","unstructured":"Bahadur S, Deshmukh R. Validated HPLC and HPTLC methods for quantitative analysis of Syringic acid in Calendula officinalis. indianjournals.com (cited 18 July 2024). https:\/\/www.indianjournals.com\/ijor.aspx?target=ijor:rjpt&volume=16&issue=4&article=064."},{"key":"3094_CR62","unstructured":"HPLC analysis of carotenoids in four varieties of Calendula officinalis L. flowers. Acta Biol Szeged. (cited 18 July 2024). https:\/\/abs.bibl.u-szeged.hu\/index.php\/abs\/article\/view\/2329."},{"key":"3094_CR63","doi-asserted-by":"publisher","unstructured":"Vidal-Ollivier E, Elias R, Faure F, Babadjamian A, Crespin F, Balansard G, et al. Flavonol glycosides from Calendula officinalis flowers. Planta Med. 1989;55:73\u20134 (cited 18 July 2024). https:\/\/doi.org\/10.1055\/s-2006-961831.","DOI":"10.1055\/s-2006-961831"},{"key":"3094_CR64","unstructured":"\u015e K, Sa\u011fl\u0131k Bilimleri Dergisi TO, Yaz\u0131s\u0131 A, Pa\u015fayeva L, Fatullayev H, Kili\u00e7 \u015e, et al. HPLC-PDA determination of pseudo taraxasterol (\u03c8-taraxasterol) in different Cousinia species. dergipark.org.tr. 2021 (cited 18 July 2024). https:\/\/dergipark.org.tr\/en\/pub\/eujhs\/issue\/61142\/632581."},{"key":"3094_CR65","doi-asserted-by":"publisher","unstructured":"Zhang X, Wang R, Finiuk N, Stoika R, Lin H, Wang X, et al. Active compounds from Calendula officinalis flowers act via PI3K and ERK signaling pathways to offer neuroprotective effects against Parkinson\u2019s disease. Food Sci Nutr 2024;12:450\u20138 (cited 19 July 2024). https:\/\/doi.org\/10.1002\/fsn3.3792.","DOI":"10.1002\/fsn3.3792"},{"key":"3094_CR66","doi-asserted-by":"publisher","unstructured":"Szakiel A, Ruszkowski D, Grudniak A, et al. Antibacterial and antiparasitic activity of oleanolic acid and its glycosides isolated from marigold (Calendula officinalis). thieme-connect.com. 2008;74:1709\u201315 (cited 18 July 2024). https:\/\/doi.org\/10.1055\/s-0028-1088315.","DOI":"10.1055\/s-0028-1088315"},{"key":"3094_CR67","unstructured":"D\u2019ambrosio M, Ciocarlan A, Colombo E, Guerriero A, Pizza C, Sangiovanni E, et al. Structure and cytotoxic activity of sesquiterpene glycoside esters from Calendula officinalis L.: studies on the conformation of viridiflorol. Elsevier. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0031942215001661 (cited 18 July 2024)."},{"key":"3094_CR68","unstructured":"Ashwlayan VD, Kumar A, Verma M, Garg VK, Gupta SK. Therapeutic potential of Calendula officinalis. 2018. researchgate.net (cited 18 July 2024). https:\/\/www.researchgate.net\/profile\/Vrish-Ashwlayan\/publication\/324744282_Therapeutic_Potential_of_Calendula_officinalis\/links\/5adfe8fc458515c60f63cfa8\/Therapeutic-Potential-of-Calendula-officinalis.pdf."},{"key":"3094_CR69","doi-asserted-by":"crossref","unstructured":"Goodwin TW. Studies in carotenogenesis. 13. The carotenoids of the flower petals of Calendula officinalis. Biochem J. 1954;58:90 (cited 18 July 2024). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1269847\/.","DOI":"10.1042\/bj0580090"},{"key":"3094_CR70","doi-asserted-by":"crossref","unstructured":"Yoshikawa M, Murakami T, et al. Medicinal flowers. III. Marigold. (1): Hypoglycemic, gastric emptying inhibitory, and gastroprotective principles and new oleanane-type triterpene oligoglycosides, calendasaponins A, B, C, and D, from Egyptian Calendula officinalis. jstage.jst.go.jp 2001 (cited 18 July 2024). https:\/\/www.jstage.jst.go.jp\/article\/cpb\/49\/7\/49_7_863\/_article\/-char\/ja\/.","DOI":"10.1248\/cpb.49.863"},{"key":"3094_CR71","unstructured":"Khan M, Rohilla A, Bhatt D, et al. Diverse belongings of Calendula officinalis: an overview. researchgate.net (cited 18 July 2024). https:\/\/www.researchgate.net\/profile\/Mohd-Masih-Khan\/publication\/273144539_Diverse_Belongings_of_Calendula_officinalis\/links\/54fa4cb20cf2040df21b4310\/Diverse-Belongings-of-Calendula-officinalis.pdf."},{"key":"3094_CR72","doi-asserted-by":"crossref","unstructured":"Olennikov DN, Kashchenko NI, Chirikova NK, Akobirshoeva A, Zilfikarov IN, Vennos C. Isorhamnetin and quercetin derivatives as anti-acetylcholinesterase principles of marigold (Calendula officinalis) flowers and preparations. mdpi.com 2017 (cited 18 July 2024). https:\/\/www.mdpi.com\/1422-0067\/18\/8\/1685.","DOI":"10.3390\/ijms18081685"},{"key":"3094_CR73","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1080\/14786419.2019.1599888","volume":"34","author":"AA Zaki","year":"2020","unstructured":"Zaki AA, Qiu L. Machaerinic acid 3-O-\u03b2-d-glucuronopyranoside from Calendula officinalis. Nat Prod Res. 2020;34:2938\u201344.","journal-title":"Nat Prod Res"},{"key":"3094_CR74","doi-asserted-by":"crossref","unstructured":"Kishimoto S, Maoka T, et al. Analysis of carotenoid composition in petals of calendula (Calendula officinalis L.). academic.oup.com 2014;69:2122\u20138 (cited 18 July 2024). https:\/\/academic.oup.com\/bbb\/article-abstract\/69\/11\/2122\/5953359.","DOI":"10.1271\/bbb.69.2122"},{"key":"3094_CR75","unstructured":"Marigold extract\u2014Calendula\u2014Cosmacon (cited 18 July 2024). https:\/\/www.cosmacon.de\/en\/marigold-extract\/."},{"key":"3094_CR76","doi-asserted-by":"crossref","unstructured":"Olennikov DN, Kashchenko NI, Chirikova NK, Akobirshoeva A, Zilfikarov IN, Vennos C. Isorhamnetin and quercetin derivatives as anti-acetylcholinesterase principles of marigold (Calendula officinalis) flowers and preparations. Int J Mol Sci. 2017;18:1685 (cited 18 July 2024). https:\/\/www.mdpi.com\/1422-0067\/18\/8\/1685\/htm.","DOI":"10.3390\/ijms18081685"},{"key":"3094_CR77","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jpba.2016.04.017","volume":"125","author":"MLL Moraes","year":"2016","unstructured":"Moraes MLL, da Silva HDT, Blanes L, Dobb P, Tavares MFM. Optimization of chemometric approaches for the extraction of isorhamnetin-3-O-rutinoside from Calendula officinalis L. J Pharm Biomed Anal. 2016;125:408\u201314.","journal-title":"J Pharm Biomed Anal"},{"key":"3094_CR78","doi-asserted-by":"publisher","unstructured":"Olennikov DN, Kashchenko NI. Calendosides I\u2013IV, new quercetin and isorhamnetin rhamnoglucosides from Calendula officinalis. Chem Nat Compd. 2014;50:633\u20137 (cited 18 July 2024). https:\/\/doi.org\/10.1007\/s10600-014-1041-6.","DOI":"10.1007\/s10600-014-1041-6"},{"key":"3094_CR79","unstructured":"Al-Snafi AE. Phenolics and flavonoids contents of medicinal plants, as natural ingredients for many therapeutic purposes\u2014a review. IOSR J Pharm. 2020;10:42\u201381 (cited 18 July 2024). www.iosrphr.org."},{"key":"3094_CR80","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0031-9422(00)88077-2","volume":"8","author":"Z Kasprzyk","year":"1969","unstructured":"Kasprzyk Z, Wojciechowski Z. Incorporation of 1\u201314C-acetate into triterpenoids in Calendula officinalis. Phytochemistry. 1969;8:1921\u20136.","journal-title":"Phytochemistry"},{"key":"3094_CR81","doi-asserted-by":"publisher","unstructured":"Verma PK, Raina R, Sultana M, Singh M, Kumar P. Total antioxidant and oxidant status of plasma and renal tissue of cisplatin-induced nephrotoxic rats: protection by floral extracts of Calendula officinalis Linn. Ren Fail. 2016;38:142\u201350 (cited 18 July 2024). https:\/\/doi.org\/10.3109\/0886022X.2015.1103585.","DOI":"10.3109\/0886022X.2015.1103585"},{"key":"3094_CR82","doi-asserted-by":"publisher","unstructured":"Vecherko LP, Sviridov AF, Zinkevich EP, Kogan LM. The structure of calendulosides C and D from the roots of Calendula officinalis. Chem Nat Compd. 1975;11:379\u201384 (cited 18 July 2024). https:\/\/doi.org\/10.1007\/BF00571213","DOI":"10.1007\/BF00571213"},{"key":"3094_CR83","doi-asserted-by":"publisher","unstructured":"Ukiya M, Akihisa T, Yasukawa K, Tokuda H, Suzuki T, Kimura Y. Anti-inflammatory, anti-tumor-promoting, and cytotoxic activities of constituents of marigold (Calendula officinalis) flowers. J Nat Prod. 2006;69:1692\u20136 (cited 18 July 2024). https:\/\/doi.org\/10.1021\/np068016b","DOI":"10.1021\/np068016b"},{"key":"3094_CR84","unstructured":"Ashwlayan V. Therapeutic potential of Calendula officinalis. 2018 (cited 19 July 2024). https:\/\/www.researchgate.net\/publication\/324744282."},{"key":"3094_CR85","unstructured":"Verma PK, Raina R, Agarwal S, Kaur H. Phytochemical ingredients and pharmacological potential of Calendula officinalis Linn. Pharm Biomed Res. 2018;4:1\u201317 (cited 19 July 2024). http:\/\/pbr.mazums.ac.ir\/article-1-199-en.html."},{"key":"3094_CR86","doi-asserted-by":"publisher","unstructured":"Lim TK. Calendula officinalis. Edible Med Non-Med. Plants. 2014;213\u201344 (cited 19 July 2024). https:\/\/doi.org\/10.1007\/978-94-007-7395-0_15.","DOI":"10.1007\/978-94-007-7395-0_15"},{"key":"3094_CR87","doi-asserted-by":"publisher","unstructured":"Ul\u2019chenko NT, Glushenkova AI, Mukhamedova KS. Lipids of Calendula officinalis. Chem Nat Compd. 1998;34:272\u20134 (cited 19 July 2024). https:\/\/doi.org\/10.1007\/BF02282400.","DOI":"10.1007\/BF02282400"},{"key":"3094_CR88","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1248\/cpb.49.863","volume":"49","author":"M Yoshikawa","year":"2001","unstructured":"Yoshikawa M, Murakami T, Kishi A, Kageura T, Matsuda H. Medicinal flowers. III. Marigold. (1): Hypoglycemic, gastric emptying inhibitory, and gastroprotective principles and new oleanane-type triterpene oligoglycosides, calendasaponins A, B, C, and D, from Egyptian Calendula officinalis. Chem Pharm Bull. 2001;49:863\u201370.","journal-title":"Chem Pharm Bull"},{"key":"3094_CR89","doi-asserted-by":"crossref","unstructured":"Rashad E, El-Wahed A, et al. And gibberellic acid on leaf angle, growth, flowering as well as biochemical constituents of marigold (Calendula officinalis) plant. jpp.journals.ekb.eg. 2008;33:7845\u201362 (cited 19 July 2024). https:\/\/jpp.journals.ekb.eg\/article_171519.html.","DOI":"10.21608\/jpp.2008.171519"},{"key":"3094_CR90","unstructured":"Rashad E, et al. Effect of-sitosterol and gibberellic acid on leaf angle, growth, flowering and biochemical constituents of marigold (Calendula officinalis L.). globalsciencebooks.info (cited 19 July 2024); http:\/\/globalsciencebooks.info\/Online\/GSBOnline\/images\/0906\/MAPSB_3(1)\/MAPSB_3(1)21-27o.pdf."},{"key":"3094_CR91","doi-asserted-by":"publisher","unstructured":"Kirmizibekmez H, Bassarello C, Piacente S, Pizza C, \u00c7ali\u015f I. Triterpene saponins from Calendula arvensis. Z Naturforsch B. 2006;61:1170\u20133 (cited 19 July 2024). https:\/\/doi.org\/10.1515\/znb-2006-0920\/html.","DOI":"10.1515\/znb-2006-0920\/html"},{"key":"3094_CR92","doi-asserted-by":"publisher","unstructured":"Khouchlaa A, El Baaboua A, El Moudden H, Lakhdar F, Bakrim S, El Menyiy N, et al. Traditional uses, bioactive compounds, and pharmacological investigations of Calendula arvensis L.: a comprehensive review. Adv Pharmacol Pharm Sci. 2023;2023:2482544 (cited 19 July 2024). https:\/\/doi.org\/10.1155\/2023\/2482544.","DOI":"10.1155\/2023\/2482544"},{"key":"3094_CR93","doi-asserted-by":"publisher","unstructured":"Karrer P, Burgi W. Two-dimensional NMR studies of triterpenoid glycosides. II-1H NMR assignment of arvensoside A and B, calenduloside C and D. Spectrosc Lett. 1951;22:579\u201384 (cited 19 July 2024). https:\/\/doi.org\/10.1080\/00387018908053907.","DOI":"10.1080\/00387018908053907"},{"key":"3094_CR94","unstructured":"Panigrahi S, Mishra US, Dixit PK, Mishra PR. Isolation and characterization of bioconstituents present in Calendula arvensis leaf. NeuroQuantology 2022;20(9):3393\u2013402."},{"key":"3094_CR95","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/0031-9422(75)83006-8","volume":"14","author":"G Adler","year":"1975","unstructured":"Adler G, Kasprzyk Z. Free sterols, steryl esters, glucosides, acylated glucosides and water-soluble complexes in Calendula officinalis. Phytochemistry 1975;14:627\u201331.","journal-title":"Phytochemistry"},{"key":"3094_CR96","unstructured":"Dictionary of food compounds with CD-ROM, 2nd edn. Google Books (cited 19 July 2024). https:\/\/books.google.iq\/books?id=_pHQQQkl8FMC&pg=PA1770&lpg=PA1770&dq=Marker,R.E.et+al.,JACS,59,(1937),2704-2708&source=bl&ots=G3ZPVLUf9N&sig=ACfU3U2en-usXXEMFvyVIcenZp_v7IcvSw&hl=en&sa=X&ved=2ahUKEwiw76uTr7OHAxUuS_EDHQVhCYQQ6AF6BAgMEAM#v=onepage&q=Marker%2CR.E.etal.%2CJACS%2C59%2C(1937)%2C2704-2708&f=false."},{"issue":"11","key":"3094_CR97","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/antiox8110559","volume":"8","author":"G Bragueto Escher","year":"2019","unstructured":"Bragueto Escher G, Do Cardoso Borges LC, Sousa Santos J, Mendanha Cruz T, Boscacci Marques M, Vieira do Carmo MA, et al. From the field to the pot: phytochemical and functional analyses of Calendula officinalis L. flower for incorporation in an organic yogurt. Antioxidants (Basel Switz). 2019;8(11):559.","journal-title":"Antioxidants (Basel Switz)"},{"key":"3094_CR98","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1039\/C6FO00398B","volume":"7","author":"M Miguel","year":"2016","unstructured":"Miguel M, Barros L, Pereira C, Calhelha RC, Garcia PA, Castro M\u00c1, et al. Chemical characterization and bioactive properties of two aromatic plants: Calendula officinalis L. (flowers) and Mentha cervina L. (leaves). Food Funct. 2016;7:2223\u201332.","journal-title":"Food Funct"},{"key":"3094_CR99","doi-asserted-by":"publisher","DOI":"10.16943\/ptinsa\/2017\/49126","author":"R John","year":"2017","unstructured":"John R, Jan N. Calendula officinalis\u2014an important medicinal plant with potential biological properties. Proc Indian Natl Sci Acad. 2017. https:\/\/doi.org\/10.16943\/ptinsa\/2017\/49126.","journal-title":"Proc Indian Natl Sci Acad"},{"key":"3094_CR100","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jff.2018.04.013","volume":"45","author":"MV Faustino","year":"2018","unstructured":"Faustino MV, Pinto DCGA, Gon\u00e7alves MJ, Salgueiro L, Silveira P, Silva AMS. Calendula L. species polyphenolic profile and in vitro antifungal activity. J Funct Foods. 2018;45:254\u201367.","journal-title":"J Funct Foods"},{"key":"3094_CR101","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1055\/s-2006-961831","volume":"55","author":"E Vidal-Ollivier","year":"1989","unstructured":"Vidal-Ollivier E, Elias R, Faure F, Babadjamian A, Crespin F, Balansard G, et al. Flavonol glycosides from Calendula officinalis flowers. Planta Med. 1989;55:73\u20134.","journal-title":"Planta Med"},{"key":"3094_CR102","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/BF00598365","volume":"22","author":"AI Derkach","year":"1987","unstructured":"Derkach AI, Komissarenko NF, Chernobai VT. Coumarins of the inflorescences of Calendula officinalis and Helichrysum arenarium. Chem Nat Compd. 1987;22:722\u20133.","journal-title":"Chem Nat Compd"},{"key":"3094_CR103","doi-asserted-by":"crossref","unstructured":"Janiszowska W, Janlszowska W, Michuki W, Kasprzyk Z. Polyprenyl quinones and \u03b1-tocopherol in Calendula officinalis. Phytochemistry 1976;15:125\u20137 (cited 20 July 2024). https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0031942200890664.","DOI":"10.1016\/S0031-9422(00)89066-4"},{"key":"3094_CR104","doi-asserted-by":"publisher","unstructured":"Okoh O, Sadimenko A, Afolayan A. The effects of age on the yield and composition of the essential oils of Calendula officinalis. 2007 (cited 20 July 2024). https:\/\/doi.org\/10.5555\/20083035010.","DOI":"10.5555\/20083035010"},{"key":"3094_CR105","unstructured":"Bak\u00f3 E, Deli J, et al. HPLC study on the carotenoid composition of Calendula products. Elsevier (cited 20 July 2024). https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0165022X02001124."},{"key":"3094_CR106","unstructured":"Frieden E, Lipsett MB, Winzler RJ, Gross J, Leblond CP, Maclagan NF, et al. Studies in carotenogenesis. 13. The carotenoids of the flower petals of Calendula officinalis. Biochem J. 1954;46:215 (cited 20 July 2024). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1269847\/."},{"key":"3094_CR107","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1016\/0031-9422(85)80062-5","volume":"24","author":"B Wi\u0142komirski","year":"1985","unstructured":"Wi\u0142komirski B. Pentacyclic triterpene triols from Calendula officinalis flowers. Phytochemistry. 1985;24:3066\u20137.","journal-title":"Phytochemistry"},{"key":"3094_CR108","doi-asserted-by":"crossref","unstructured":"Zitterl-Eglseer K, Sosa S, Jurenitsch J, Schubert-Zsilavecz M, Della Loggia R, Tubaro A, et al. Anti-oedematous activities of the main triterpendiol esters of marigold (Calendula officinalis L.). J Ethnopharmacol. 1997;57:139\u201344 (cited 20 July 2024). https:\/\/pubmed.ncbi.nlm.nih.gov\/9254116\/.","DOI":"10.1016\/S0378-8741(97)00061-5"},{"key":"3094_CR109","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S0031-9422(00)88473-3","volume":"11","author":"Z Wojciechowski","year":"1972","unstructured":"Wojciechowski Z, Boche\u0144ska-Hryniewicz M, Kucharczak B, Kasprzyk Z. Sterol and triterpene alcohol esters from Calendula officinalis. Phytochemistry 1972;11:1165\u20138.","journal-title":"Phytochemistry"},{"key":"3094_CR110","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/0031-9422(73)85141-6","volume":"12","author":"Z Kasprzyk","year":"1973","unstructured":"Kasprzyk Z, Wi\u0142komirski B. Structure of a new triterpene triol from Calendula officinalis flowers. Phytochemistry 1973;12:2299\u2013300.","journal-title":"Phytochemistry"},{"key":"3094_CR111","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0031-9422(00)84638-5","volume":"12","author":"J \u015aliwowski","year":"1973","unstructured":"\u015aliwowski J, Dziewanowska K, Kasprzyk Z. Ursadiol: a new triterpene diol from Calendula officinalis flowers. Phytochemistry 1973;12:157\u201360.","journal-title":"Phytochemistry"},{"key":"3094_CR112","doi-asserted-by":"crossref","unstructured":"Zitterl-Eglseer K, Reznicek G, Jurenitsch J, Novak J, Zitterl W, Franz C. Morphogenetic variability of faradiol monoesters in marigold Calendula officinalis L. Phytochem Anal. 2001;12:199\u2013201 (cited 20 July 2024). https:\/\/pubmed.ncbi.nlm.nih.gov\/11705026\/.","DOI":"10.1002\/pca.582"},{"key":"3094_CR113","doi-asserted-by":"crossref","unstructured":"Ashwlayan VD, Kumar A, Verma M, Garg VK, Gupta S. Therapeutic potential of Calendula officinalis. Pharm Pharmacol Int J. 2018;6 (cited 20 July 2024). https:\/\/medcraveonline.com\/PPIJ\/PPIJ-06-00171.php.","DOI":"10.15406\/ppij.2018.06.00171"},{"key":"3094_CR114","doi-asserted-by":"crossref","unstructured":"Bak\u00f3 E, Deli J, T\u00f3th G. HPLC study on the carotenoid composition of Calendula products. J Biochem Biophys Methods. 2002;53:241\u201350 (cited 20 July 2024). https:\/\/pubmed.ncbi.nlm.nih.gov\/12406606\/.","DOI":"10.1016\/S0165-022X(02)00112-4"},{"key":"3094_CR115","doi-asserted-by":"crossref","unstructured":"Goodwin TW. Studies in carotenogenesis. 13. The carotenoids of the flower petals of Calendula officinalis. Biochem J. 1954;58:90\u20134 (cited 20 July 2024). https:\/\/pubmed.ncbi.nlm.nih.gov\/13198857\/.","DOI":"10.1042\/bj0580090"},{"key":"3094_CR116","doi-asserted-by":"publisher","unstructured":"Abasova RL, Aslanov SM, Mamedova M\u00c9. Amino acids of Calendula officinalis. Chem Nat Compd. 1995;30:641 (cited 20 July 2024). https:\/\/doi.org\/10.1007\/BF00629888.","DOI":"10.1007\/BF00629888"},{"key":"3094_CR117","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0031-9422(79)80064-3","volume":"18","author":"B Wilkomirski","year":"1979","unstructured":"Wilkomirski B, Kasprzyk Z. Free and ester-bound triterpene alcohols and sterols in cellular subfractions of Calendula officinalis flowers. Phytochemistry. 1979;18:253\u20135.","journal-title":"Phytochemistry"},{"key":"3094_CR118","doi-asserted-by":"publisher","unstructured":"Ul\u2019chenko NT, Glushenkova AI, Mukhamedova KS. Lipids of Calendula officinalis. Chem Nat Compd. 1998;34:272\u20134 (cited 20 July 2024). https:\/\/doi.org\/10.1007\/BF02282400.","DOI":"10.1007\/BF02282400"},{"key":"3094_CR119","doi-asserted-by":"crossref","unstructured":"Willuhn G, Westhaus R-G. Loliolide (Calendin) from Calendula officinalis. Planta Med. 1987;53:304 (cited 20 July 2024). https:\/\/pubmed.ncbi.nlm.nih.gov\/17269033\/.","DOI":"10.1055\/s-2006-962718"},{"key":"3094_CR120","doi-asserted-by":"publisher","unstructured":"Bal\u00e1zs VL, Guly\u00e1s-Fekete G, Nagy V, Zubay P, Szab\u00f3 K, S\u00e1ndor V, et al. Carotenoid composition of Calendula officinalis flowers with identification of the configuration of 5, 8-epoxy-carotenoids. ACS Agric Sci Technol. 2023;3:1092\u2013102 (cited 19 July 2024). https:\/\/doi.org\/10.1021\/acsagscitech.3c00367.","DOI":"10.1021\/acsagscitech.3c00367"},{"key":"3094_CR121","doi-asserted-by":"crossref","unstructured":"Shahane K, Kshirsagar M, Tambe S, Jain D, Rout S, Ferreira MKM, et al. An updated review on the multifaceted therapeutic potential of Calendula officinalis L. Pharmaceuticals. 2023;16:611 (cited 19 July 2024). https:\/\/www.mdpi.com\/1424-8247\/16\/4\/611\/htm.","DOI":"10.3390\/ph16040611"},{"key":"3094_CR122","doi-asserted-by":"crossref","unstructured":"Hakeem IJ, Alsharif FH, Aljadani M, Alabbas IF, Faqihi MS, Aloufi AH, et al. Molecular docking analysis of KRAS inhibitors for cancer management. Bioinformation. 2023;19:411 (cited 29 Sep 2025). https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10563554\/.","DOI":"10.6026\/97320630019411"},{"key":"3094_CR123","doi-asserted-by":"crossref","unstructured":"Ostrem JM, Peters U, Sos ML, Wells JA, Shokat KM. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature. 2013;503:548\u201351 (cited 29 Sep 2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/24256730\/.","DOI":"10.1038\/nature12796"},{"key":"3094_CR124","unstructured":"Gras J. Sotorasib. Drugs Future. 2023;46:521\u20138 (cited 29 Sep 2025). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK595115\/."},{"key":"3094_CR125","doi-asserted-by":"crossref","unstructured":"Final report on the safety assessment of Calendula officinalis extract and Calendula officinalis. Int J Toxicol. 2001;20(Suppl 2):13\u201320 (cited 29 Sep 2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/11558637\/.","DOI":"10.1080\/10915810160233721"},{"key":"3094_CR126","doi-asserted-by":"publisher","unstructured":"Ogunyemi BT, Abdul-Hammed M, Olaide Adedotun I, Basirat, Egunjobi T, Suleiman, et al. Protein\u2013ligand molecular dynamics simulation (PL-MDS), ADMET analyses, and bioactivity studies of phytochemicals from Aloe vera: an in-silico novel antidiabetics drug discovery effort. Discov Chem. 2025;2:1\u201325 (cited 20 Sep 2025). https:\/\/doi.org\/10.1007\/s44371-025-00130-1.","DOI":"10.1007\/s44371-025-00130-1"},{"key":"3094_CR127","doi-asserted-by":"crossref","unstructured":"Genheden S, Ryde U. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov. 2015;10:449\u201361 (cited 30 Sep 2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/25835573\/.","DOI":"10.1517\/17460441.2015.1032936"},{"key":"3094_CR128","doi-asserted-by":"crossref","unstructured":"Gond C, Kumar N, Singh VK, Datta A, Tiwari AK. Exploring novel ligands for mGluR5: design, computational analysis, and protein\u2013ligand interaction studies. Chem Phys Impact. 2024;9:100691 (cited 30 Sep 2025). https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2667022424002354.","DOI":"10.1016\/j.chphi.2024.100691"},{"key":"3094_CR129","doi-asserted-by":"publisher","unstructured":"Justino GC, Nascimento CP, Justino MC. Molecular dynamics simulations and analysis for bioinformatics undergraduate students. Biochem Mol Biol Educ. 2021;49:570\u201382 (cited 30 Sep 2025). https:\/\/doi.org\/10.1002\/bmb.21512.","DOI":"10.1002\/bmb.21512"},{"key":"3094_CR130","doi-asserted-by":"crossref","unstructured":"Alnajjar R, Mostafa A, Kandeil A, Al-Karmalawy AA. Molecular docking, molecular dynamics, and in vitro studies reveal the potential of angiotensin II receptor blockers to inhibit the COVID-19 main protease. Heliyon. 2020;6 (cited 14 May 2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/33294721\/.","DOI":"10.1016\/j.heliyon.2020.e05641"},{"key":"3094_CR131","doi-asserted-by":"crossref","unstructured":"Wang Y, Zhou Y, Khan FI, Wang Y, Zhou Y, Khan FI. Molecular insights into structural dynamics and binding interactions of selected inhibitors targeting SARS-CoV-2 main protease. Int J Mol Sci. 2024;25:13482 (cited 5 April 2025). https:\/\/www.mdpi.com\/1422-0067\/25\/24\/13482\/htm.","DOI":"10.3390\/ijms252413482"},{"key":"3094_CR132","doi-asserted-by":"crossref","unstructured":"Zhou HX, Pang X. Electrostatic interactions in protein structure, folding, binding, and condensation. Chem Rev. 2018;118:1691 (cited 5 April 2025). https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5831536\/.","DOI":"10.1021\/acs.chemrev.7b00305"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03094-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03094-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03094-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T03:50:43Z","timestamp":1769485843000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03094-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":132,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["3094"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03094-5","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studied with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"29"}}